Preview Mode Links will not work in preview mode

This Week in Cardiology

Jan 5, 2024

Neuro-modulation in HF, private equity owned hospitals, HCM, SCD and ICD re-evaluated, and peer review are the topics John Mandrola, MD, discusses in this week’s podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

I. Neuromodulation for HFrEF

FDA Expands Label for CVRx Barostim System in HF

BeAT HF trial

II. Private Equity Takeover of US Hospitals

Hospital Adverse Events Rise After Private Equity Acquisition

Changes in Hospital Adverse Events and Patient Outcomes Associated With Private Equity Acquisition:

RSS audio:

III. Hypertrophic Cardiomyopathy

Positive Topline Results for SEQUOIA-HCM Trial in OHCM

IV. The ICD gets a ReLook

Study to Examine Routine ICD Implantation Post Heart Attack


Declining Risk of Sudden Death in Heart Failure

V. Peer Review

Prevalence of Short Peer Reviews in 3 Leading General Medical Journals --

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact news@medscape.n